We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$319M
Cap. Flow
-$362M
Cap. Flow %
-18.57%
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60

Top Buys

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$127M
2
CLDR
Cloudera, Inc.
CLDR
+$103M
3
CVA
Covanta Holding Corporation
CVA
+$55.8M
4
WBT
Welbilt, Inc.
WBT
+$54.6M
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$49.5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$326M
2
MXIM
Maxim Integrated Products
MXIM
+$234M
3
WORK
Slack Technologies, Inc.
WORK
+$111M
4
PRAH
PRA Health Sciences, Inc.
PRAH
+$90M
5
NAV
Navistar International
NAV
+$73.8M

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Technology 15.69%
3 Industrials 13.34%
4 Communication Services 11.51%
5 Healthcare 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWBK
26
DELISTED
Switchback II Corporation
SWBK
$11.9M 0.61%
1,191,945
+789,890
+196% +$7.84M
INOV
27
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$11.6M 0.6%
+288,285
New +$10.9M
CIIGU
28
DELISTED
CIIG Capital Partners II, Inc. Unit
CIIGU
$10.1M 0.52%
+1,000,719
New +$10.1M
MUDS
29
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$9.88M 0.51%
+993,064
New +$10.4M
GLS
30
DELISTED
Gelesis Holdings, Inc.
GLS
$9.43M 0.48%
950,377
+37,011
+4% +$365K
GMBT
31
DELISTED
Pivotal Holdings Corp Class A Ordinary Share
GMBT
$9.09M 0.47%
+921,085
New +$9.02M
ASAQ
32
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$8.65M 0.44%
883,264
+31,982
+4% +$312K
GPGI
33
GPGI Inc
GPGI
$4.26B
$8.57M 0.44%
+1,020,665
New +$8.56M
DCRN
34
DELISTED
Decarbonization Plus Acquisition Corporation II Class A Common stock
DCRN
$8.45M 0.43%
855,659
+744,091
+667% +$7.35M
BOWX
35
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$8.17M 0.42%
+816,664
New +$8.38M
BURU icon
36
NUBURU INC
BURU
$8.13M 0.42%
4,166
-6
-0.1% -$11.7K
SPAQ
37
DELISTED
Spartan Acquisition Corp. III
SPAQ
$8.12M 0.42%
+821,675
New +$8.08M
FRSG
38
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$8.06M 0.41%
+819,498
New +$8.02M
HCIC
39
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$8.04M 0.41%
814,879
+712,208
+694% +$7.09M
GIG
40
DELISTED
GigCapital4, Inc. Common stock
GIG
$7.97M 0.41%
808,472
+64,254
+9% +$632K
NVTS icon
41
Navitas Semiconductor
NVTS
$3.12B
$7.7M 0.4%
771,644
+666,988
+637% +$6.64M
NSTB
42
DELISTED
Northern Star Investment Corp. II
NSTB
$7.7M 0.39%
775,253
+527,677
+213% +$5.24M
TOI icon
43
The Oncology Institute
TOI
$543M
$7.65M 0.39%
769,766
+700,667
+1,014% +$6.96M
TMTS
44
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$7.56M 0.39%
747,185
+77,284
+12% +$777K
MACQ
45
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
$7.4M 0.38%
749,512
+622,629
+491% +$6.09M
AUS
46
DELISTED
Austerlitz Acquisition Corporation I
AUS
$7.24M 0.37%
+728,566
New +$7.22M
PL icon
47
Planet Labs
PL
$8.23B
$7.1M 0.36%
+716,635
New +$7.1M
BSN
48
DELISTED
Broadstone Acquisition Corp.
BSN
$6.94M 0.36%
+697,923
New +$6.9M
CFV
49
DELISTED
CF Acquisition Corp. V Class A Common Stock
CFV
$6.79M 0.35%
+686,094
New +$6.75M
PEAR
50
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$6.61M 0.34%
+664,495
New +$6.57M
1
2
3 4 5

Similar funds

XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return
BU
BBVA USA Birmingham, Alabama $1.71B AUM
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
FMW
Farr Miller & Washington Washington, District of Columbia $1.53B AUM 32.74% 1-Year Est. Return
MAFM
Mid Atlantic Financial Management Pittsburgh, Pennsylvania $1.49B AUM 24.08% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return

Omni Partners US's Q3 2021 Portfolio in Review

As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.

  • Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
  • Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
  • Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
  • Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
  • Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
  • Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
  • Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.